Galactosylceramide beta Galactosidase Deficiency Disease is a rare genetic disorder that affects the metabolism of lipids in the body. This condition, also known as Krabbe disease, results in the insufficient activity of the galactosylceramidase enzyme, leading to the accumulation of toxic substances in the nervous system. The condition primarily affects infants and presents symptoms such as developmental regression, muscle weakness, and vision problems. Synonyms for Galactosylceramide beta Galactosidase Deficiency Disease include Krabbe leukodystrophy, globoid cell leukodystrophy, and galactosylceramidase deficiency. It is important to raise awareness about this condition to facilitate early diagnosis and intervention for affected individuals, as well as promote research into potential treatments and therapies.